相关实验视频

Updated: May 6, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

生物反应性水凝用于按需的非荷尔蒙避孕药

Giovanni M Pauletti¹, Pankaj Dwivedi¹, Ping Li²

¹Department of Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, University of Health Sciences and Pharmacy in St. Louis, St. Louis, MO 63110, USA.

Gels (Basel, Switzerland)

|November 26, 2025

概括

一种新的生物反应性水凝 (CP4%/PVP4%) 通过对精液反应来增强避孕障碍. 这种无药水凝显著降低了精子的运动和迁移,为预防怀孕提供了安全有效的屏障.

科学领域:

生物材料科学生物材料科学
生殖生物学生殖生物学
药物输送系统药物输送系统

背景情况:

生物反应性水凝为治疗应用提供可调节的特性.
现有的避孕方法存在局限性,推动了创新解决方案的需求.
加强自然避孕障碍是一个有希望的无毒方法.

研究的目的:

研究一种生物反应性水凝 (CP4%/PVP4%) 作为一种无药避孕障碍物.
为了评估水凝对精液的反应的结构变化.
评估水凝在减少精子运动和迁移方面的有效性.

主要方法:

一种含有Carbopol® 974P和聚烯罗利 (CP4%/PVP4%) 的水凝的配方.
水凝暴露于模拟的精液 (pH 7.7) 和人类精液.
在体外评估精子迁移和运动.
在体外和体内生物安全性评估.
在子体内进行的探索性研究,将疗效与市场上销售的产品进行比较.

主要成果:

在暴露于模拟精液后,CP4%/PVP4%水凝表现出生物反应性结构变化.
与人类精子结合,体外精子迁移减少了97%,精子运动率低于生育标准.
在体外和体内生物安全性评估表明,它具有有利的特征.
水凝在体内显示出与子中的VCF®凝相似的预防怀孕的有效性.

结论:

生物反应性CP4%/PVP4%水凝作为一种有效的无药避孕屏障.
水凝的机制涉及结构变化,阻碍了与精子接触后的精子功能.
这种水凝是一种有前途的,安全的,有效的替代品,用于按需的避孕.

关键词:

没有毒品,没有毒品.由女性发起的女性倡议.独立于合作伙伴的独立.物理避孕措施的障碍物.

更多相关视频

Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning

Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning

Published on: April 16, 2018

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

相关概念视频

Birth Control Methods

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...

Oral Drug Delivery Systems: Continuous-Release Systems

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...